![Seth J. Orlow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth J. Orlow
Direttore/Membro del Consiglio presso
ALMIRALL, S.A.
Profilo
Seth J.
Orlow was the founder of Ivrea Pharmaceuticals, Inc. (founded in 2005) and held the title of Director.
Dr. Orlow is also the founder of Anaderm Research Corp.
Dr. Orlow's current job(s) include being a Professor & Chairman-Perelman Dermatology at NYU Grossman School of Medicine since 2006, an Independent Director at Almirall SA since 2016, and a Director at R2 Dermatology, Inc., R2 Technologies, Inc. (California), and New York University.
Dr. Orlow's former job(s) include being a Director at Coapt Systems, Inc., Protez Pharmaceuticals, Inc., Transave, Inc., and a Managing Director at Easton Capital Investment Group.
Dr. Orlow also served as a Trustee at the Dermatology Foundation.
Dr. Orlow's education history includes a doctorate degree from Albert Einstein College of Medicine, Inc. and an undergraduate degree from Harvard College.
Posizioni attive di Seth J. Orlow
| Società | Posizione | Inizio |
|---|---|---|
| ALMIRALL, S.A. | Direttore/Membro del Consiglio | 01/01/2016 |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
R2 Dermatology, Inc.
 R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company based in New York, NY. The CEO of the company is Gordon E. Nye. | Direttore/Membro del Consiglio | - |
R2 Technologies, Inc. (California)
 R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots | Direttore/Membro del Consiglio | - |
Nyu Grossman School of Medicine
 Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2006 |
Precedenti posizioni note di Seth J. Orlow
| Società | Posizione | Fine |
|---|---|---|
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Direttore/Membro del Consiglio | - |
Dermatology Foundation | Direttore/Membro del Consiglio | - |
Anaderm Research Corp. | Fondatore | - |
Ivrea Pharmaceuticals, Inc.
 Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions | Fondatore | - |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Seth J. Orlow
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Coapt Systems, Inc.
 Coapt Systems, Inc. BiotechnologyHealth Technology Manufactures and markets bioabsorbable implants | Health Technology |
Ivrea Pharmaceuticals, Inc.
Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions | Health Technology |
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Protez Pharmaceuticals, Inc.
 Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
Easton Capital Investment Group
 Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Finance |
Dermatology Foundation | |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anaderm Research Corp. | |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R2 Dermatology, Inc.
R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company based in New York, NY. The CEO of the company is Gordon E. Nye. | |
R2 Technologies, Inc. (California)
R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots | Health Technology |
Nyu Grossman School of Medicine
Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
